Genotech Corporation

A066830

KR7066830001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
1,589 ^KRW	+7.00%		-0.25%	-16.24%

2018	Genotech Corp. announced that it has received KRW 399.99753 million in funding	CI
2018	Genotech Corp. announced that it expects to receive KRW 399.99753 million in funding	CI

Genotech Corp. announced that it has received KRW 399.99753 million in funding

December 10, 2018

On December 11, 2018, Genotech Corp. (XKON:A066830) closed the transaction.

Latest news about Genotech Corporation

Genotech Corp. announced that it has received KRW 399.99753 million in funding	18-12-10	CI
Genotech Corp. announced that it expects to receive KRW 399.99753 million in funding	18-12-02	CI
Ceres F&D Co., ltd. announced that it has received KRW 999.999 million in funding from Genotech Corp.	18-09-03	CI
Ceres F&D Co., ltd. announced that it expects to receive KRW 999.999 million in funding from Genotech Corp.	18-08-28	CI
Genotech Corp. announced that it has received KRW 1 billion in funding from Midas Donga Investment Co.,Ltd.	18-04-29	CI
Genotech Corp. announced that it expects to receive KRW 1 billion in funding from Midas Donga Investment Co.,Ltd.	18-04-23	CI

Genotech Corporation is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through three segments. Bio-Phamaceutical segment is involved in the manufacturing and sale of the main ingredients of finished pharmaceuticals such as antibiotics and immunosuppressants. Deoxyribonucleic Acid (DNA) & Ribonucleic Acid (RNA) Synthesis segment is involved in the manufacturing and sale of materials for biotechnology research including gene manipulation, polymerase chain reaction (PCR), cloning, and sequencing. Genome Analysis Service segment is involved in the analysis of the gene sequences of the samples requested by customers and the provision of analysis results.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GENOTECH CORPORATION	-16.24%	6.43M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+31.77%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.42%	240B
NOVARTIS AG	+9.45%	210B
ROCHE HOLDING AG	-5.44%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals

Genotech Corporation

Equities

A066830

KR7066830001

Pharmaceuticals

Genotech Corp. announced that it has received KRW 399.99753 million in funding

Latest news about Genotech Corporation

Chart Genotech Corporation

Company Profile

Sector Other Pharmaceuticals